Table 2 Comparison of general clinical characteristics between the pARDS and non-pARDS groups.

From: Risk assessment of pARDS in severe pneumonia patients based on lung injury prediction scores and serum biomarkers

Variable

pARDS

n = 30

Non-pARDS

n = 67

P

WBC [×109/L, median (IQR)]

10.71 (7.30,14.90)

9.61 (6.74,13.42)

0.365

Platelet Count [×109/L, median (IQR)]

354 (267,498)

345 (260,474)

0.628

Creatinine [µmol/L, median (IQR)]

21.55 (17.58,25.80)

18.80 (15.58,22.70)

0.078

D-dimer [mg/L, median (IQR)]

0.31 (0.22,0.41)

0.35 (0.22,0.91)

0.152

Total Protein (g/L, Mean ± SD)

56.70 ± 8.36

57.34 ± 9.14

0.742

Albumin Levels (g/L, Mean ± SD)

35.54 ± 5.65

35.86 ± 6.14

0.809

PCIS (Mean ± SD)

81.73 ± 5.87

84.34 ± 4.81

0.023a

Length of Hospital Stay [d, median (IQR)]

24 (18,34)

17 (13,23)

0.006a

  1. a: Statistically significant at p < 0.05; P < 0.05 statistically significant; pARDS: pediatric acute respiratory distress syndrome; non-pARDS: non-pediatric acute respiratory distress syndrome; PCIS: pediatric critical illness score.
Back to article page